Sign In

Login

Password

Forgot Password ? Sign Up

Inhibitory zwrotnego wychwytu serotoniny i noradrenaliny (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inhibitory zwrotnego wychwytu serotoniny i noradrenaliny" in Polish language version.

refsWebsite
Global rank Polish rank
12nih.gov
4th place
7th place
11doi.org
2nd place
6th place
1web.archive.org
1st place
1st place

doi.org

doi.org

  • publikacja w otwartym dostępie – możesz ją przeczytać Jean Pierre Olie, David Gourion, Agnes Montagne, Michel Rostin i inni. Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: A 24-week randomized, double-blind exploratory study. „Neuropsychiatric Disease and Treatment”. 6 (1), s. 71–79, 2010. DOI: 10.2147/NDT.S10184. PMID: 20396639. PMCID: PMC2854083. 
  • David S Baldwin. Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders. „International Journal of Psychiatry in Clinical Practice”. 10 (Suppl2), s. 12–15, 2006. DOI: 10.1080/13651500600637056. PMID: 24921677. 
  • Natalie J. Carter, Paul L. McCormack. Duloxetine: A review of its use in the treatment of generalized anxiety disorder. „CNS Drugs”. 23 (6), s. 523–541, 2009. DOI: 10.2165/00023210-200923060-00006. PMID: 19480470. 
  • Toshihiko Nagata, Jun Oshima, Akira Wada, Hisashi Yamada i inni. Open trial of milnacipran for Taijin-Kyofusho in Japanese patients with social anxiety disorder. „International Journal of Psychiatry in Clinical Practice”. 7 (2), s. 107–112, 2003. DOI: 10.1080/13651500310000690. 
  • Harsh Chalana. A case report of milnacipran in phantom-limb pain. „Asian Journal of Psychiatry”. 3 (3), s. 155–156, 2010. DOI: 10.1016/j.ajp.2010.07.009. PMID: 23051576. 
  • Kunie Nakajima, Hideaki Obata, Nobuhisa Iriuchijima, Shigeru Saito. An increase in spinal cord noradrenaline is a major contributor to the antihyperalgesic effect of antidepressants after peripheral nerve injury in the rat. „Pain”. 153 (5), s. 990–997, 2012. DOI: 10.1016/j.pain.2012.01.029. PMID: 22424692. 
  • Bettahalasoor Somashekar, Ashok Jainer, Balaji Wuntakal. Psychopharmacotherapy of somatic symptoms disorders. „International Review of Psychiatry”. 25 (1), s. 107–115, 2013. DOI: 10.3109/09540261.2012.729758. PMID: 23383672. 
  • publikacja w otwartym dostępie – możesz ją przeczytać Ciara McCabe, Zevic Mishor. Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers. „NeuroImage”. 57 (4), s. 1317–1323, 2011. DOI: 10.1016/j.neuroimage.2011.05.051. PMID: 21640839. PMCID: PMC3141109. 
  • publikacja w otwartym dostępie – możesz ją przeczytać Keith Hawton, Helen Bergen, Sue Simkin, Jayne Cooper i inni. Toxicity of antidepressants: Rates of suicide relative to prescribing and non-fatal overdose. „The British Journal of Psychiatry”. 196 (5), s. 354–358, 2010. DOI: 10.1192/bjp.bp.109.070219. PMID: 20435959. PMCID: PMC2862059. 
  • Marian Christoph, Bernd Ebner, Dirk Stolte, Karim Ibrahim i inni. Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine. „European Neuropsychopharmacology”. 20 (8), s. 594–597, 2010. DOI: 10.1016/j.euroneuro.2010.03.009. PMID: 20451358. 

dx.doi.org

  • Michele Mancini i inni, Evaluation of the effect of duloxetine treatment on functioning as measured by the Sheehan disability scale: pooled analysis of data from six randomized, double-blind, placebo-controlled clinical studies, „International Clinical Psychopharmacology”, 6, 27, 2012, s. 298–309, DOI: 10.1097/YIC.0b013e3283589a3f, PMID: 22954893.

nih.gov

ncbi.nlm.nih.gov

  • publikacja w otwartym dostępie – możesz ją przeczytać Jean Pierre Olie, David Gourion, Agnes Montagne, Michel Rostin i inni. Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: A 24-week randomized, double-blind exploratory study. „Neuropsychiatric Disease and Treatment”. 6 (1), s. 71–79, 2010. DOI: 10.2147/NDT.S10184. PMID: 20396639. PMCID: PMC2854083. 
  • Michele Mancini i inni, Evaluation of the effect of duloxetine treatment on functioning as measured by the Sheehan disability scale: pooled analysis of data from six randomized, double-blind, placebo-controlled clinical studies, „International Clinical Psychopharmacology”, 6, 27, 2012, s. 298–309, DOI: 10.1097/YIC.0b013e3283589a3f, PMID: 22954893.
  • David S Baldwin. Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders. „International Journal of Psychiatry in Clinical Practice”. 10 (Suppl2), s. 12–15, 2006. DOI: 10.1080/13651500600637056. PMID: 24921677. 
  • Martin A. Katzman, Alex Copeland, Larry Klassen, Pratap Chokka i inni. Pharmacotherapy for generalized anxiety disorder. „Psychiatric Annals”. 41 (2), s. 95–103, 2011. PMID: 12562113. 
  • Natalie J. Carter, Paul L. McCormack. Duloxetine: A review of its use in the treatment of generalized anxiety disorder. „CNS Drugs”. 23 (6), s. 523–541, 2009. DOI: 10.2165/00023210-200923060-00006. PMID: 19480470. 
  • Harsh Chalana. A case report of milnacipran in phantom-limb pain. „Asian Journal of Psychiatry”. 3 (3), s. 155–156, 2010. DOI: 10.1016/j.ajp.2010.07.009. PMID: 23051576. 
  • Kunie Nakajima, Hideaki Obata, Nobuhisa Iriuchijima, Shigeru Saito. An increase in spinal cord noradrenaline is a major contributor to the antihyperalgesic effect of antidepressants after peripheral nerve injury in the rat. „Pain”. 153 (5), s. 990–997, 2012. DOI: 10.1016/j.pain.2012.01.029. PMID: 22424692. 
  • publikacja w otwartym dostępie – możesz ją przeczytać Jay D Kranzler, R. Michael Gendreau. Role and rationale for the use of milnacipran in the management of fibromyalgia. „Neuropsychiatric Disease and Treatment”. 6 (1), s. 197–208, 2010. PMID: 20520784. PMCID: PMC2877602. 
  • Bettahalasoor Somashekar, Ashok Jainer, Balaji Wuntakal. Psychopharmacotherapy of somatic symptoms disorders. „International Review of Psychiatry”. 25 (1), s. 107–115, 2013. DOI: 10.3109/09540261.2012.729758. PMID: 23383672. 
  • publikacja w otwartym dostępie – możesz ją przeczytać Ciara McCabe, Zevic Mishor. Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers. „NeuroImage”. 57 (4), s. 1317–1323, 2011. DOI: 10.1016/j.neuroimage.2011.05.051. PMID: 21640839. PMCID: PMC3141109. 
  • publikacja w otwartym dostępie – możesz ją przeczytać Keith Hawton, Helen Bergen, Sue Simkin, Jayne Cooper i inni. Toxicity of antidepressants: Rates of suicide relative to prescribing and non-fatal overdose. „The British Journal of Psychiatry”. 196 (5), s. 354–358, 2010. DOI: 10.1192/bjp.bp.109.070219. PMID: 20435959. PMCID: PMC2862059. 
  • Marian Christoph, Bernd Ebner, Dirk Stolte, Karim Ibrahim i inni. Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine. „European Neuropsychopharmacology”. 20 (8), s. 594–597, 2010. DOI: 10.1016/j.euroneuro.2010.03.009. PMID: 20451358. 

web.archive.org